chr12-121641283-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The ENST00000617316.2(ORAI1):​c.546C>T​(p.Ile182Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.176 in 1,614,070 control chromosomes in the GnomAD database, including 27,597 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.16 ( 2215 hom., cov: 33)
Exomes 𝑓: 0.18 ( 25382 hom. )

Consequence

ORAI1
ENST00000617316.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4O:1

Conservation

PhyloP100: -0.831
Variant links:
Genes affected
ORAI1 (HGNC:25896): (ORAI calcium release-activated calcium modulator 1) The protein encoded by this gene is a membrane calcium channel subunit that is activated by the calcium sensor STIM1 when calcium stores are depleted. This type of channel is the primary way for calcium influx into T-cells. Defects in this gene are a cause of immune dysfunction with T-cell inactivation due to calcium entry defect type 1 (IDTICED1). [provided by RefSeq, Sep 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 12-121641283-C-T is Benign according to our data. Variant chr12-121641283-C-T is described in ClinVar as [Benign]. Clinvar id is 379393.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.831 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.313 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ORAI1NR_186857.1 linkn.764C>T non_coding_transcript_exon_variant Exon 2 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ORAI1ENST00000617316.2 linkc.546C>T p.Ile182Ile synonymous_variant Exon 3 of 3 1 ENSP00000482568.2 Q96D31-1
ORAI1ENST00000611718.1 linkn.602C>T non_coding_transcript_exon_variant Exon 2 of 2 5
ORAI1ENST00000646827.1 linkn.744C>T non_coding_transcript_exon_variant Exon 2 of 2
ORAI1ENST00000698901.1 linkn.668C>T non_coding_transcript_exon_variant Exon 2 of 2

Frequencies

GnomAD3 genomes
AF:
0.156
AC:
23739
AN:
152110
Hom.:
2209
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0868
Gnomad AMI
AF:
0.259
Gnomad AMR
AF:
0.241
Gnomad ASJ
AF:
0.214
Gnomad EAS
AF:
0.253
Gnomad SAS
AF:
0.327
Gnomad FIN
AF:
0.118
Gnomad MID
AF:
0.234
Gnomad NFE
AF:
0.160
Gnomad OTH
AF:
0.178
GnomAD2 exomes
AF:
0.203
AC:
50725
AN:
249926
AF XY:
0.207
show subpopulations
Gnomad AFR exome
AF:
0.0842
Gnomad AMR exome
AF:
0.300
Gnomad ASJ exome
AF:
0.198
Gnomad EAS exome
AF:
0.258
Gnomad FIN exome
AF:
0.119
Gnomad NFE exome
AF:
0.163
Gnomad OTH exome
AF:
0.188
GnomAD4 exome
AF:
0.178
AC:
260437
AN:
1461844
Hom.:
25382
Cov.:
34
AF XY:
0.183
AC XY:
132880
AN XY:
727222
show subpopulations
Gnomad4 AFR exome
AF:
0.0871
AC:
2915
AN:
33480
Gnomad4 AMR exome
AF:
0.294
AC:
13150
AN:
44712
Gnomad4 ASJ exome
AF:
0.201
AC:
5244
AN:
26136
Gnomad4 EAS exome
AF:
0.240
AC:
9512
AN:
39700
Gnomad4 SAS exome
AF:
0.331
AC:
28538
AN:
86258
Gnomad4 FIN exome
AF:
0.123
AC:
6564
AN:
53406
Gnomad4 NFE exome
AF:
0.163
AC:
181535
AN:
1111988
Gnomad4 Remaining exome
AF:
0.189
AC:
11422
AN:
60396
Heterozygous variant carriers
0
15835
31670
47504
63339
79174
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
6672
13344
20016
26688
33360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.156
AC:
23783
AN:
152226
Hom.:
2215
Cov.:
33
AF XY:
0.161
AC XY:
11948
AN XY:
74432
show subpopulations
Gnomad4 AFR
AF:
0.0871
AC:
0.08708
AN:
0.08708
Gnomad4 AMR
AF:
0.242
AC:
0.241895
AN:
0.241895
Gnomad4 ASJ
AF:
0.214
AC:
0.213998
AN:
0.213998
Gnomad4 EAS
AF:
0.253
AC:
0.253483
AN:
0.253483
Gnomad4 SAS
AF:
0.326
AC:
0.326285
AN:
0.326285
Gnomad4 FIN
AF:
0.118
AC:
0.117925
AN:
0.117925
Gnomad4 NFE
AF:
0.160
AC:
0.160284
AN:
0.160284
Gnomad4 OTH
AF:
0.181
AC:
0.181173
AN:
0.181173
Heterozygous variant carriers
0
1053
2105
3158
4210
5263
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
280
560
840
1120
1400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.171
Hom.:
4338
Bravo
AF:
0.161
Asia WGS
AF:
0.311
AC:
1081
AN:
3478
EpiCase
AF:
0.177
EpiControl
AF:
0.174

ClinVar

Significance: Benign
Submissions summary: Benign:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Oct 20, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 51% of patients studied by a panel of primary immunodeficiencies. Number of patients: 48. Only high quality variants are reported. -

not provided Benign:1Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -

Combined immunodeficiency due to ORAI1 deficiency;C4014557:Myopathy, tubular aggregate, 2 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
3.4
DANN
Benign
0.79
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3741595; hg19: chr12-122079189; COSMIC: COSV57491137; API